159 related articles for article (PubMed ID: 17013849)
21. Progress in the development of small molecule therapeutics targeting Th17 cell function for the treatment of immune-inflammatory diseases.
Shuttleworth S; Townsend P; Silva F; Cecil A; Hill T; Tomassi C; Rogers H; Harrison R
Prog Med Chem; 2011; 50():109-33. PubMed ID: 21315929
[No Abstract] [Full Text] [Related]
22. The murky world of the COX-2-selective agents.
Bjarnason I; Thjodleifsson B
Inflammopharmacology; 2005; 13(4):381-93. PubMed ID: 16354391
[No Abstract] [Full Text] [Related]
23. Economic evaluation of nonsteroidal anti-inflammatory drug strategies in rheumatoid arthritis.
Inotai A; Mészáros A
Int J Technol Assess Health Care; 2009 Apr; 25(2):190-5. PubMed ID: 19366498
[TBL] [Abstract][Full Text] [Related]
24. Sex differences in effects and use of anti-inflammatory drugs.
Demyanets S; Wojta J
Handb Exp Pharmacol; 2012; (214):443-72. PubMed ID: 23027462
[TBL] [Abstract][Full Text] [Related]
25. An evidence-based review of the cardiovascular risks of nonsteroidal anti-inflammatory drugs.
Farkouh ME; Greenberg BP
Am J Cardiol; 2009 May; 103(9):1227-37. PubMed ID: 19406264
[TBL] [Abstract][Full Text] [Related]
26. Prevention of nonsteroidal anti-inflammatory drug-induced ulcer: looking to the future.
Fiorucci S
Gastroenterol Clin North Am; 2009 Jun; 38(2):315-32. PubMed ID: 19446261
[TBL] [Abstract][Full Text] [Related]
27. Cyclooxygenase-2 inhibitors and other nonsteroidal anti-inflammatory drugs in the treatment of musculoskeletal conditions.
Austin MS; Abdul-Hadi O; Parvizi J; Viscusi ER; Einhorn T
Instr Course Lect; 2009; 58():759-68. PubMed ID: 19385584
[TBL] [Abstract][Full Text] [Related]
28. Coxibs, non-steroidal anti-inflammatory drugs and cardiovascular risk.
Woodruff T
Intern Med J; 2006 Dec; 36(12):797-8; author reply 798-9. PubMed ID: 17096747
[No Abstract] [Full Text] [Related]
29. To use or not to use: the dilemma of NSAIDs and craniotomy.
Umamaheswara Rao GS; Gelb AW
Eur J Anaesthesiol; 2009 Aug; 26(8):625-6. PubMed ID: 19584610
[No Abstract] [Full Text] [Related]
30. Drug insight: cyclo-oxygenase-2 inhibitors--a critical appraisal.
Hinz B; Renner B; Brune K
Nat Clin Pract Rheumatol; 2007 Oct; 3(10):552-60; quiz 1 p following 589. PubMed ID: 17906610
[TBL] [Abstract][Full Text] [Related]
31. Are we ignoring the elephant in the room?
Jindeel A
Arch Intern Med; 2007 Nov; 167(20):2263-4. PubMed ID: 17998505
[No Abstract] [Full Text] [Related]
32. [Osteoporosis pain management].
Dinges G
Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 Sep; 44(9):568-77. PubMed ID: 19750435
[TBL] [Abstract][Full Text] [Related]
33. Impact of protein-glycan interactions in the regulation of autoimmunity and chronic inflammation.
Bianco GA; Toscano MA; Ilarregui JM; Rabinovich GA
Autoimmun Rev; 2006 May; 5(5):349-56. PubMed ID: 16782561
[TBL] [Abstract][Full Text] [Related]
34. Selective COX-2 inhibitors: a promise unfulfilled?
Henry D; McGettigan P
Gastroenterology; 2007 Feb; 132(2):790-4. PubMed ID: 17261306
[No Abstract] [Full Text] [Related]
35. Gastrointestinal and cardiovascular risks of nonsteroidal anti-inflammatory drugs.
Jones R; Rubin G; Berenbaum F; Scheiman J
Am J Med; 2008 Jun; 121(6):464-74. PubMed ID: 18501223
[TBL] [Abstract][Full Text] [Related]
36. COXIBs and non-selective NSAIDs in the gastroenterological setting: what should patients and physicians do?
Lazzaroni M; Battocchia A; Bianchi Porro G
Dig Liver Dis; 2007 Jun; 39(6):589-96. PubMed ID: 17459794
[TBL] [Abstract][Full Text] [Related]
37. [Cardiovascular toxicity of selective COX-2-inhibitors and classical NSAIDs].
Lange H; Eberhart L
Anasthesiol Intensivmed Notfallmed Schmerzther; 2007 Jul; 42(7):514-7. PubMed ID: 17661262
[TBL] [Abstract][Full Text] [Related]
38. The effect of low-dose aspirin on the decreased risk of development of dyspepsia and gastrointestinal ulcers associated to cyclooxygenase-2 selective inhibitors.
Benito-Garcia E; Michaud K; Wolfe F
J Rheumatol; 2007 Aug; 34(8):1765-9. PubMed ID: 17611980
[TBL] [Abstract][Full Text] [Related]
39. The prevention of gastropathy and upper abdominal symptoms caused by nonsteroidal anti-inflammatory drugs.
Vakil N
Rev Gastroenterol Disord; 2006; 6(4):221-6. PubMed ID: 17224894
[TBL] [Abstract][Full Text] [Related]
40. Identification of patients taking NSAIDs at high risk for GI bleeding.
Harris J; Lee SB; Plowman BK; Morreale AP; Boggie DT; Delattre ML
Am J Health Syst Pharm; 2005 Aug; 62(15):1543, 1548. PubMed ID: 16030358
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
